In the first of a two-part series with TB and HIV experts at the Bill & Melinda Gates Foundation, Dr. Stefano Bertozzi, director of HIV and tuberculosis programs at the Foundation, gives his thoughts on what lies ahead this year in HIV and TB building on key developments from the past year and a half. In his role, Dr. Bertozzi oversees grants in HIV vaccine development, biomedical prevention research, diagnostics development and resistance monitoring, and strategies for introduction and scaling-up of interventions. He has held past leadership roles at UNAIDS, the World Health Organization, the World Bank, and the National Institute of Public Health (INSP) in Mexico.
Oct. 7, 2017 SAN DIEGO – Dr. Edsel Salvaña has two posters in the exhibit hall here, each one carrying terrible news from the Philippines, that, […]
GUADALAJARA, Mexico – For all the emphasis on new tuberculosis treatments and repurposed drugs to meet the World Health Organization’s End TB goals at the Union […]
Report gives evidence that neurological impacts of Zika go beyond effects on brain development By the time pediatric pathologists explored the cases reported in the August […]
Global health data review finds no country on track to end TB incidence by 2030, vast majority of countries falling short of goals to control HIV
Projections based on current burdens of disease, along with data from the preceding 26 years, show both vast inequalities of progress, as well as the likelihood […]